Cyclin-dependent kinase inhibitors move into Phase III

被引：60
|
作者：
Guha, Malini
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2012年 / 11卷 / 12期
关键词：
D O I：
10.1038/nrd3908
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
After more than a decade of clinical development for cancer and numerous failures, Phase III trials of cyclin-dependent kinase inhibitors are beginning.
引用
收藏
页码：892 / 894
页数：3
相关论文
共 50 条
  • [31] Cyclin-dependent kinase inhibitors closer to market launch?
    Galons, Herve
    Oumata, Nassima
    Gloulou, Olfa
    Meijer, Laurent
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (08) : 945 - 963
  • [32] Functional analysis of cyclin-dependent kinase inhibitors of Arabidopsis
    De Veylder, L
    Beeckman, T
    Beemster, GTS
    Krols, L
    Terras, P
    Landrieu, I
    Van der Schueren, E
    Maes, S
    Naudts, M
    Inzé, D
    PLANT CELL, 2001, 13 (07): : 1653 - 1667
  • [33] ROLE OF THE CYCLIN-DEPENDENT KINASE INHIBITORS IN THE DEVELOPMENT OF CANCER
    HIRAMA, T
    KOEFFLER, HP
    BLOOD, 1995, 86 (03) : 841 - 854
  • [34] Cyclin-dependent kinase inhibitors: novel anticancer agents
    Mani, S
    Wang, CG
    Wu, KM
    Francis, R
    Pestell, R
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (08) : 1849 - 1870
  • [35] Cyclin-dependent kinase 7 inhibitors in cancer therapy
    Wang, Minmin
    Wang, Tianyu
    Zhang, Xiangyu
    Wu, Xiaoxing
    Jiang, Sheng
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 813 - 833
  • [36] Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies
    Baghdassarian, N
    Ffrench, M
    HEMATOLOGY AND CELL THERAPY, 1996, 38 (04): : 313 - 323
  • [37] Cyclin-dependent kinase inhibitors for the treatment of lung cancer
    Qin, Angel
    Reddy, Haritha G.
    Weinberg, Frank D.
    Kalemkerian, Gregory P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (08) : 941 - 952
  • [38] Inhibitors of the Cyclin-Dependent Kinase and PIM Kinase Pathways in the Treatment of Myeloma
    Ramakrishnan, Vijay G.
    Kumar, Shaji K.
    CANCER JOURNAL, 2016, 22 (01): : 7 - 11
  • [39] PRECLINICAL AND CLINICAL DEVELOPMENT OF CYCLIN-DEPENDENT KINASE AND CHECKPOINT KINASE INHIBITORS
    Shapiro, G. I.
    ANNALS OF ONCOLOGY, 2010, 21 : 27 - 27
  • [40] Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation
    Gondeau, C
    Gerbal-Chaloin, S
    Bello, P
    Aldrian-Herrada, G
    Morris, MC
    Divita, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (14) : 13793 - 13800
12345